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Abstract
Background: Cervical ripening is an important prerequisite for successful induction of labor, a procedure that is frequently
necessary because of medical or obstetrical complications. Of several methods of ripening, intracervical dinoprostone gel
and intravaginal misoprostol tablet are the most frequently used methods.
Aims andObjectives: To compare the efﬁcacy and safety of intracervical dinoprostone gel and intravaginal misoprostol
tablet as a cervical ripening agent.
Materials andMethods: A total of 138 pregnant women satisfying the inclusion criteria were studied. They were divided
into two groups: 72 in group 1 (dinoprostone gel) and 66 in group 2 (misoprostol tablet). The safety and efﬁcacy of both the
drugs were analyzed. The primary outcome variables were change in Bishop’s score, induction to delivery (I-D) time, Apgar
score, and incidence of abnormal uterine action. The secondary outcome variables were need for oxytocin, indication for
caesarean section, and mode of delivery. Statistical analysis was done using the unpaired t-test and w2-test.
Results: No difference was observed between the two groups with respect to change in Bishop’s score (3.015 vs 3.625,
p4 0.05), but I-D time was more for group 1 (i.e., 15.04 vs 11.48 h, po 0.05). Apgar scores were also similar in both the
groups, that is, the number of babies with Apgar score of o8 at 5 min was 3 for group 1 vs 6 for group 2, p 4 0.05.
Abnormal uterine action was not seen at all in group 1, whereas three patients had this problem in group 2. In secondary
variables, requirement of oxytocin was more in group 1 (i.e., 48 vs 22, p o 0.05). In various indications of caesarean
section, none got operated for abnormal uterine action in group 1, whereas three patients got operated for this reason in
group 2. Mode of delivery was similar in both the groups.
Conclusions: Dinoprostone and misoprostol are similar in their action on cervical ripening. Misoprostol has an added
beneﬁt of being a uterotonic agent. Therefore, it has less I-D time. Low-dose of misoprostol has decreased the incidence of
side effects.
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Introduction
Cervical ripening is an important prerequisite for successful
induction of labor, a procedure that is frequently necessary
because of medical or obstetrical complications. Of several
methods of ripening, intracervical dinoprostone gel and
intravaginal misoprostol tablet are the most frequently used
methods.
Dinoprostone or PGE2 gel is a good cervical ripening
agent, whereas misoprostol has action on both cervical
ripening and uterine contractions. Misoprostol has various
advantages such as lower cost and no need for refrigeration.[1]
It can cause problems such as fetal distress and uterine
hyperstimulation.[2] Vaginal application of low-dose (25 mg)
misoprostol has been reported in women worldwide and
seems to have safety proﬁle similar to that of dinoprostone,
especially in high-risk pregnancies, but resulted in fewer
adverse effects.[3] Other trials involve use of isosorbide
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mononitrate and a combination of dinoprostone and oxytocin,
but they are not very effective.[4,5]
The aim of this study was to compare the safety and
efﬁcacy of intracervical dinoprostone gel with that of intrava-
ginal misoprostol tablet as a cervical ripening agent.
Material andMethods
This study was conducted in 2010 on patients with various
indications for termination of labor. The inclusion criteria were
singleton pregnancy (at term), cephalic presentation, reassuring
fetal heart rate (FHR) monitoring pattern, and cervical Bishop’s
score of o5. The exclusion criteria were premature rupture
of membranes; active labor; vaginal bleeding; placenta previa;
history of caesarean section; cephalopelvic disproportion;
and history of asthma or glaucoma, multipara 43, and
malpresentation.
A total of 138 pregnant women satisfying the inclusion
criteria were studied. They were randomly divided into two
groups (Table 1): 72 in group 1 (dinoprostone gel) and 66 in
group 2 (misoprostol tablet). In group 1, dinoprostone gel was
administered intracervically (0.5 mg) and repeated 6 hourly
for 3 doses, if required. In group 2, misoprostol tablet was
kept vaginally (25 mg) and repeated 4 hourly for a maximum of
6 doses, if required. Bishop’s score assessed favorability of
cervix. Patients were closely monitored for drug complications
such as abnormal uterine action and fetal heart sound
irregularity.
An oxytocin infusion was started when Bishop’s score was
5 or more in the absence of spontaneous labor. Patient was
given option of elective lower segment caesarean section if
cervical score did not improve even after maximum allowed
dose of ripening agent. All patients were monitored during
labor using electronic FHR monitoring. Artiﬁcial rupture of the
membranes was generally performed when cervix was more
than 5 cm dilated and 80% effaced.
The primary outcome variables were change in Bishop’s
score, induction to delivery (I-D) time, Apgar score, and
incidence of abnormal uterine action. The secondary outcome
variables were need for oxytocin, mode of delivery, and
indications for caesarean section in both the groups. Statistical
analysis was done using unpaired t-test and w2-test.
Result
Of 138 patients, 72 were administered dinoprostone and
66 were given misoprostol. The demographic characteristics
of patients distributed according to age, parity, gestationa
age, and initial Bishop’s score are given in Table 1. The
table shows that the change in Bishop’s score after the
administration of drug was similar in both the groups
(i.e., 3.015 vs 3.625, p 4 0.05).
The various indications for induction are shown in Table 2.
The maximum number of induction was found to be for
postdated pregnancy. More patients required oxytocin for
progress of labor in group 1 (66% vs 34%). This was
statistically signiﬁcant (w2-test analysis). So that, I-D time (in
hours) was more in group 1, as shown in Table 3 (i.e., 15.04 vs
11.48 h, p o 0.05).
The complications in both the groups were similar except
that group 2 had three patients with abnormal uterine action
and three with APH, whereas these were absent in group 1
[Table 4].
The modes of delivery were similar in both the groups, that
is, no difference in caesarean section rate was observed in
both the groups (i.e., 12 vs 15) [Table 5].
Table 6 shows that no difference in average birth weight
was observed between the two groups. While more patients
got operated for failed induction in group 1, more patients in
group 2 got operated for abnormal uterine action and fetal
distress. This was not statistically signiﬁcant.
Discussion
The induction of labor is an important part of modern
obstetrics. The most common indication being postdatism
among others.[6] The success of induction of labor depends on
good cervical ripening. This study compared the efﬁcacy and
safety of low-dose misoprostol to that of dinoprostone gel as a
cervical ripening agent.
At the dose of 25 mg, misoprostol had less I-D time and
lesser requirement of oxytocin. This was similar to most other
studies. Although Cochrane Database review[7] stated that
better results were obtained with dose higher than 25 mg
misoprostol. Kulshreshtha et al.[8] showed I-D time of 6.92 h in
misoprostol (100 mg) group.
Table 1: Distribution of patients
Parameters Group 1 (mean ± SD) Group 2 (mean ± SD) t-Value p-Value
Age 23 ± 3.75 24 ± 3.31 1.6546 0.1003
Parity 2.1 ± 1.82 2.3 ± 1.54 0.6936 0.4891
Gestational age (weeks) 37.5 ± 1.58 38.15 ± 3.03 1.5989 0.1122
Initial Bishop’s score 3.018 ± 2.49 3.190 ± 2.156 0.4320 0.6664
Change in Bishop’s score 3.015 ± 2.16 3.625 ± 2.86 1.4211 0.1576
*Unpaired t-test is used for analysis.
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In the context of side effects, Apgar scores at 5 min were
similar in both the groups of our study, that is, the number of
babies with Apgar score of o8 at 5 min was three in group 1
and six in group 2. This difference was not statistically
signiﬁcant.
Kulshreshtha et al.[8] showed no difference in both the
groups even at a higher misoprostol dose of 100 mg. This was
reiterated in Cochrane Database review[7]. Crane et al.[9]
showed increased incidence of meconium staining at dose
more than 25 mg misoprostol.
The second problem was that of abnormal uterine action
such as hyperstimulation. In our study, three patients had this
problem in group 2 as compared to none in group 1. Cochrane
Database review[7] showed increased incidence with more
than 25 mg dose, whereas Kulshreshtha et al.[8] showed same
incidence at 100 mg dose. But all other studies were in
agreement that caesarean section rate does not change in
both the groups as in our study.[10,11]
Conclusion
Both dinoprostone and misoprostol are good ripening
agents, but misoprostol has an edge because of its additional
uterotonic action, thereby reducing the I-D time. Using low-dose
misoprostol for induction of labor can reduce the incidence of
its side effects.
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